By Lucia Maffei Women are increasingly joining the ranks of angel investors, and now make up almost half of angel investors nationwide, according to a new report. Last year, women angels represented 46.7% of the angel market, marking the third year in a row of increased participation. Women angels accounted for 39.5% of the market in […]
By Hannah Green Venture capital funding to life sciences companies appears to be rebounding nationally after a few down years, according to new data from Pitchbook and the National Venture Capital Association. But that’s not the case among Massachusetts life sciences companies. Nationally, life sciences companies brought in $19.3 billion in the first six months of 2024. Last […]
By Lucia Maffei Shares of HubSpot Inc. plunged in Wednesday afternoon trading after Bloomberg reported that Google parent company Alphabet put the brakes on its rumored acquisition of the Cambridge-based marketing firm. On Wednesday HubSpot’s stock (NYSE: HUBS) closed down 12.22%, giving the company a market capitalization of $25.06 billion. When rumors of a potential deal first emerged in April, the markets were valuing […]
Boston, MA The Chiofaro Company has commenced on Phase II of the $100 million reinvestment and reimagination of International Place – a 1.8 million s/f office property. A beloved landmark on the city’s skyline, International Place has long been touted for its innovative expression and distinctive architecture. International Place reflects the diversity of industries and tenant […]
By Hannah Green Eli Lilly and Co. is buying a Waltham biotech in a deal valued at around $3.2 billion. The startup being acquired is Morphic Holding Inc. (NASDAQ: MORF), a Waltham company working on treatments for chronic diseases such as types of inflammatory bowel disease. Indianapolis-based Lilly (NYSE: LLY) plans to acquire all outstanding shares of […]
By Hannah Green Moderna Inc. officially opened the doors to its new global headquarters on Wednesday, fulfilling its plan to bring its research and development operations under one roof. The Cambridge drugmaker has moved into a six-floor, 462,000-square-foot office and lab building at 325 Binney St. Moderna (Nasdaq: MRNA) first shared its intention to move into a new Cambridge […]
By Hannah Green The former CEO of Dyne Therapeutics Inc. has joined Forbion as the life sciences venture capital firm announced plans to expand its U.S. presence by opening a Boston office. Josh Brumm, formerly of Dyne and a newly named general partner at Forbion, said the Boston office “really does have a chance to impact the […]
By Marq Burnett As the hybrid era ramped up after the pandemic, experts warned that proximity bias would be difficult to avoid. Now that employers are in the midst of their hybrid models — and some are even moving past them — new data suggests fears about proximity bias, or the tendency to gravitate toward employees who are physically […]
By Trajan Warren Just ahead of its expected completion of merging with Cambridge Trust, Eastern Bank has announced four Cambridge Trust board members who will join Eastern’s Boards of Directors upon closure of the deal. When the merger is completed, Denis Sheahan, current chairman, president and CEO of Cambridge, will join Eastern’s Board of Directors, along […]
By Greg Ryan Boston University has agreed to pay $19.8 million to purchase a site on the edge of its campus that has city approval for a 17-story tower with more than 250 residences. The property is next to the planned future home of West Station, a new transit hub featuring commuter-rail service. The transaction means that […]
